Redirected Auto T Cells for Advanced Myeloma

Clinical trial NCT01352286 · COMPLETED

Trial details

NCT number: NCT01352286
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2011-05-13
Primary completion: 2017-08-25
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.